What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?	Arrhythmias, Cardiac, Arterial Occlusive Diseases, Embolism, Embolism and Thrombosis, Hemorrhage, Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, acute coronary syndrome, arteriosclerosis disorder, atrial fibrillation, atrial flutter, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder	Recruiting	Phase 4	2023-12-15		NCT04436978

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daiichi Sankyo	144
St. Antonius Hospital	45

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam UMC	Amsterdam	Netherlands	85
ASZ Aalst	Aalst	Belgium	2
AZ Delta	Roeselare	Belgium	25
AZ Groeninge	Kortrijk	Belgium	18
AZ Maria Middelares Gent	Ghent	Belgium	1
Catharina Ziekenhuis	Eindhoven	Netherlands	43
Elisabeth TweeSteden ziekenhuis	Tilburg	Netherlands	6
HagaZiekenhuis	The Hague	Netherlands	18
Imelda Ziekenhuis	Bonheiden	Belgium	4
Jan Yperman	Ieper	Belgium	2
Noordwest Ziekenhuisgroep	Alkmaar	Netherlands	21
OLVG	Amsterdam	Netherlands	21
St. Antonius Hospital	Nieuwegein	Netherlands	14
Tergooi MC	Hilversum	Netherlands	11
Treant Zorggroep	Emmen	Netherlands	6
UZ Antwerpen	Antwerp	Belgium	6
UZ Brussel	Brussels	Belgium	20
UZ Leuven	Leuven	Belgium	82
Ziekenhuis Oost-Limburg	Genk	Belgium	16
Zuyderland ziekenhuis	Heerlen	Netherlands	2

Clinical trials